var data={"title":"Desogestrel: International drug information (concise)","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Desogestrel: International drug information (concise)</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/681870?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F23673929\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">International Brand Names</span>\n    <ul>\n      <li>Aizea (GB);</li>\n      <li>Antigone (FR);</li>\n      <li>Arlette (CL, CO, PE, PY, VE);</li>\n      <li>Azalia (BG, CZ, ES, HU, IE, LV, PL);</li>\n      <li>Babette (DE);</li>\n      <li>Bredicon (BD);</li>\n      <li>Camelia (AR);</li>\n      <li>Carmin (AR, UY);</li>\n      <li>Celea (BE);</li>\n      <li>Cerazet (ES, IT);</li>\n      <li>Cerazette (AE, AR, AT, BE, BH, BR, CH, CL, CO, CR, CZ, DE, DK, DO, EC, EE, FI, FR, GB, GR, GT, HK, HN, HR, HU, ID, IE, IL, IN, IS, IT, JO, KW, LB, LT, LU, LV, MY, NI, NL, NO, NZ, PA, PE, PH, PL, PT, QA, RO, RU, SA, SE, SG, SI, SK, SV, TH, UY, VE);</li>\n      <li>Cerelle (GB);</li>\n      <li>Charozetta (UA);</li>\n      <li>Clareal (FR);</li>\n      <li>Desirett (EE, ID, LV);</li>\n      <li>Desomono (GB);</li>\n      <li>Desorox (GB);</li>\n      <li>Diamilla (DK, EE);</li>\n      <li>Embevio (VN);</li>\n      <li>Feanolla (GB);</li>\n      <li>Fleur (CZ);</li>\n      <li>Juliet (BR);</li>\n      <li>Kelly (BR);</li>\n      <li>Lactafem (PE);</li>\n      <li>Laktynet (UA);</li>\n      <li>Lueva (BE, ES);</li>\n      <li>Nacrez (DK, GB);</li>\n      <li>Nactali (BR);</li>\n      <li>Pink (AR);</li>\n      <li>Pop-D (BD);</li>\n      <li>Vanish (CL, PY);</li>\n      <li>Zelleta (GB);</li>\n      <li>Zerogen (IN)</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F20869674\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Contraceptive, Oral (Progestin)</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F20869658\" class=\"block iuse drugH1Div\"><span class=\"drugH1\">Reported Use</span>\n    <p style=\"text-indent:0em;display:inline\">Prevention of pregnancy</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F20869659\" class=\"block idos drugH1Div\"><span class=\"drugH1\">Dosage Range</span>\n    <p style=\"text-indent:0em;display:inline\">Oral: Adults: Females: Contraception:</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">No previous hormonal contraceptive use: Dosage is 1 tablet daily without interruption starting on day 1 (first day of menstrual bleeding). May start later (on days 2-5), but alternative/barrier method of contraception is recommended for 7 days following the first dose.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Following first trimester abortion: Dosage is 1 tablet daily without interruption starting immediately. No additional contraceptive method necessary.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Following delivery or second trimester abortion: Dosage is 1 tablet daily without interruption. May be started prior to return of menstruation. If starting therapy &gt;21 days postpartum/abortion, additional/barrier method of contraception is recommended for the 7 days following the first dose.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>Switching from other contraceptive methods</i>: Dosage is 1 tablet daily without interruption.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Switching from combination oral contraceptive, vaginal ring, or transdermal patch: Start therapy on the day following the last active tablet or on the day of removal of vaginal ring or transdermal patch. No additional contraceptive method necessary.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Switching from progestogen-only contraceptive: May switch any day; take first desogestrel tablet when next scheduled dose is due or on day of removal of implant/continuous release dosage form.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>Missed dose &lt;12 hours elapsed</i>: Dose (1 tablet) can be taken immediately and then resume regular schedule</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>Missed dose &gt;12 hours elapsed</i>: Dose should be skipped and resume regular schedule. Alternate form of contraception recommended for the following 7 days.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">\n      <b>Dosage adjustment in renal impairment:</b> No dosage adjustment provided in manufacturer's labeling</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosage adjustment in hepatic impairment:</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mild-to-moderate impairment: No dosage adjustment provided in manufacturer&rsquo;s labeling; use with caution</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Severe impairment: Use is contraindicated</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F20869676\" class=\"block prod-avail drugH1Div\"><span class=\"drugH1\">Product Availability</span>\n    <p style=\"text-indent:0em;display:inline\">Product available in various countries; not currently available in the US</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F20869677\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;\">Tablet, oral: 75 mcg</p></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"topicVersionRevision\">Topic 90026 Version 20.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"International Brand Names\" href=\"#F23673929\" class=\"outlineLink\">International Brand Names</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F20869674\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Reported Use\" href=\"#F20869658\" class=\"outlineLink\">Reported Use</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Range\" href=\"#F20869659\" class=\"outlineLink\">Dosage Range</a></li><li class=\"plainItem\"><a sectionName=\"Product Availability\" href=\"#F20869676\" class=\"outlineLink\">Product Availability</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F20869677\" class=\"outlineLink\">Dosage Forms</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_INT/90026|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div>","javascript":null}